| |
| |
|
| Insider
Information: |
Mcclellan William D. Jr. |
| Relationship: |
Director |
| City: |
Georgetown |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
39,249 |
|
|
Indirect Shares
|
2,000 |
|
|
| Direct
Value |
$392,490 |
|
|
|
Indirect Value
|
$20,000 |
|
|
| Total
Shares |
41,249 |
|
|
| Total
Value |
$412,490 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -27.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apollo Endosurgery, Inc |
APEN |
Director |
2022-06-14 |
39,249 |
2019-08-16 |
2,000 |
Premium* |
|
|
Reata Pharmaceuticals Inc |
RETA |
Director |
2023-09-26 |
0 |
2020-11-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2023-09-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,017) |
0 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2023-07-28 |
4 |
AS |
$164.49 |
$822,442 |
D/D |
(5,000) |
6,017 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2023-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
11,017 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2023-06-07 |
4 |
A |
$93.61 |
$167,375 |
D/D |
1,788 |
6,017 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
14,224 |
39,249 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2022-01-03 |
4 |
A |
$27.32 |
$1,612 |
D/D |
59 |
59 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,888 |
25,025 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2020-11-12 |
4 |
S |
$172.44 |
$691,669 |
D/D |
(4,000) |
0 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2020-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2020-11-09 |
4 |
AS |
$150.01 |
$600,040 |
D/D |
(4,000) |
0 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Director |
– • – |
2020-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2020-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,257 |
21,137 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2019-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
5,399 |
10,880 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,873 |
5,481 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,608 |
2,608 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2017-05-17 |
4 |
B |
$6.18 |
$10,794 |
I/I |
1,700 |
2,000 |
2.1 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2017-05-16 |
4 |
B |
$6.19 |
$1,857 |
I/I |
300 |
300 |
2.02 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
